Direct-to-consumer stem cell marketing and regulatory responses

Stem Cells Translational Medicine

Volumn 2, Issue 9, 2013, Pages 638-640

  Sipp, Douglas ^a  

^a RIKEN Center for Biosystems Dynamics Research   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COSMETIC; STEM CELL COSMETIC; UNCLASSIFIED DRUG;

ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; FOOD AND DRUG ADMINISTRATION; GOVERNMENT; HUMAN; LAW ENFORCEMENT; PLASTIC SURGERY; STEM CELL; UNITED STATES;

EID: 84883355116     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2013-0040     Document Type: Article

References (20)

1. Zarzeczny A, Caulfield T. Stem cell tourism and doctors' duties to minors: A view from Canada. Am J Bioeth 2010;10:3-15.
2. Institute of Medicine of the National Academies. Medical Devices and the Public's Health: The FDA 510(k) Clearance Process at 35 Years. Consensus report. Washington, D.C.: Institute of Medicine of the National Academies, 2011.
3. Cytori Therapeutics Inc. v. FDA, D.C. Cir., No. 11-1268.
4. Cohen PJ. Science, politics, and the regulation of dietary supplements: It's time to repeal DSHEA. Am J Law Med 2005;31:175-214.
5. Stemtech Health Sciences. Everything Stemtech. Available at http://rsvp4life.net. Accessed March 4, 2013.
6. Sipp D. Stem cell stratagems in alternative medicine. Regen Med 2011;6:407-414.
7. Liang BA, Hartman KM. It's only skin deep: FDA regulation of skin care cosmetics claims. Cornell J Law Public Policy 1999;8:249-280.
8. Eaves FF 3rd, Haeck PC, Rohrich RJ. ASAPS/ASPS position statement on stem cells and fat grafting. Plast Reconstr Surg 2012;129: 285-287.
9. U.S. Code of Federal Regulations, Title 21, Part 1271 (2012). Available at http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart_1271. Accessed March 4, 2013.
10. Casewatch. Stem cell swindler charged with fraud. Available at http://www.casewatch.org/doj/biomark/indictment.html. Accessed March 4, 2013.
11. United States of America v. Regenerative Sciences, LLC et al., Civil Action No. 2010-1327 (RMC) U.S. District Court DC (2012). https://ecf.dcd.uscourts.gov/cgi-bin/show_public_doc?2010cv1327-47. Accessed March 4, 2013.
12. Kaiser J. Stem cells: Texas Medical Board approves rules for controversial treatment. Science 2012;336:284.
13. Cyranoski D. Stem cells in Texas: Cowboy culture. Nature 2013;494:166-168.
14. Preventive therapy [Editorial]. Nature 2013;494:147-148.
15. U.S. District Attorney's Office, Southern District of Texas. Convictions entered in two separate Texas cases involving stem cells. Available at http://www.justice.gov/usao/txs/1News/Releases/2012%20September/120907%20Morales%20and%20Stowe.html. Accessed March 4, 2013.
16. CBS News. Encinitaswomanpleads guilty to treating patients without a license. Available at http://www.cbs8.com/story/19867994/encinitas-woman-pleads-guilty-to-treatingpatients-without-a-license. Accessed March 4, 2013.
17. Florida Dept. of Health v. Zannos G. Grekos. DOAH Case No. 11-4240PL.
18. Freeman L. Bonita Springs stem-cell doctor asks judge to dismiss state's case against him. Naples News. February 9, 2013. Available at http://www.naplesnews.com/news/2013/feb/09/bonita-springs-stem-cell-doctor-grekoslicense/. Accessed March 4, 2013.
19. Intercellular Sciences website. Available at http://www.intercellularsciences.com. Accessed March 4, 2013.
20. Turner L. Adult stem cell banks and clinics marketing stem cell procedures in Texas. Health in the Global Village blog. September 17, 2012. Available at http://www.healthintheglobalvillage.com/2012/09/17/adult-stem-cell-banks-and-clinics-marketingstem-cell-procedures-in-texas/. Accessed March 4, 2013.